9th November 2023
After four years as co-chairs of The PM Society, we are excited to be passing the baton on to our new Chair, Dom Marchant, it is also a great time to reflect on what has been achieved.
After four years as co-chairs of The PM Society, we are excited to be passing the baton on to our new Chair, Dom Marchant, it is also a great time to reflect on what has been achieved.
The phrase “AI will not replace you, a person using it will” probably sums up how those working in #pharmamarketing and #medicalcommunications fields think about the acceleration we’ve seen in #AI since last November.
Demystifying the early use of AI in Pharma marketing. It is a rapidly evolving field that we are just starting to explore in pharma marketing.
In this podcast, The Red Thread, we discuss an expanded framework for thinking about the ‘red thread’ and some practical examples of the red thread in action in digital pharma tactics, innovation and also at a personal level.
By 2025, 50% of content will be modular, according to The Veeva Executive Content Innovation Council.
Pharmaceutical companies have two main choices when looking to build and maintain relationships with doctors and other healthcare professionals (HCPs):
This article explores what this means for medical education. What is the future (and the very real present) that we should be recognising to better support the education of HCPs?
The world has undeniably undergone a digital transformation, with all industries now offering us as consumers a choice of how we engage with them. Unfortunately the pharmaceutical industry is a little late to the party.
Today we explore the role consent plays in helping the Healthcare and Bio-Pharma Industry market medicines and services to healthcare professionals.
Whether you have clicked on this article because the title has ruffled a few feathers, or because you are in eager agreement – let’s take a step back and get on the same page by defining and aligning on what Omnichannel is.